TScan Therapeutics (NASDAQ:TCRX) Given Outperform Rating at Wedbush
TScan Therapeutics (NASDAQ:TCRX – Get Free Report)‘s stock had its “outperform” rating restated by Wedbush in a research report issued to clients and investors on Wednesday,RTT News reports. They presently have a $7.00 price target on the stock. Wedbush’s target price suggests a potential upside of 236.54% from the company’s previous close. A number of […]
More Stories
Asking Rents Decline in November: Zillow
By Naveen Athrappully Home rents across the United States edged down in November, in line with a slowdown usually seen...
US Department of State Issues Travel Advisory Against 2 Middle Eastern Countries
By Naveen Athrappully The U.S. Department of State renewed its travel advisory for two Middle Eastern nations—Yemen and Jordan—last week...
Paramount Updates Warner Bros. Offer, Affirms Ellison Family Backing
By Andrew Moran Paramount Skydance amended its offer to buy Warner Bros. Discovery on Dec. 22, guaranteeing backing from Oracle...
Japan to Resume Operations at World’s Largest Nuclear Plant 15 Years After Fukushima Disaster
By Rachel Roberts Japan is set to resume operations at the world’s largest nuclear power plant, marking a key development...
Who is Yeonjun? Band, Age, Albums, and Updates
One of the eldest and all-around band members of TXT (TOMORROW X TOGETHER), Yeonjun. He is the only member born...
Skip the Spa: Achieving Relaxation with a Backyard Sauna Kit
A luxurious spa visit is no longer necessary for those seeking a tranquil and calming environment for relaxation. Many homeowners...